BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35894202)

  • 1. [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].
    Xie JB; Lin XZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):832-837. PubMed ID: 35894202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
    He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
    Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of caffeine on diaphragmatic activity in preterm infants.
    Dani C; Fusco M; Manti S; Marseglia L; Ciarcià M; Leonardi V; Corsini I; Gitto E
    Pediatr Pulmonol; 2023 Jul; 58(7):2104-2110. PubMed ID: 37144862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current research status of drug therapy for apnea of prematurity].
    Chen C; Shu XX; Yang XY; Shi J; Tang J; Mu DZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Sep; 18(9):806-811. PubMed ID: 27655534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apnea of prematurity - characteristic and treatment].
    Goryniak A; Szczęśniak A; Śleboda D; Dołęgowska B
    Postepy Biochem; 2017; 63(2):151-154. PubMed ID: 28689383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine Therapy for Apnea of Prematurity: Role of the Circadian
    Guo HL; Long JY; Hu YH; Liu Y; He X; Li L; Xia Y; Ding XS; Chen F; Xu J; Cheng R
    Front Pharmacol; 2021; 12():724145. PubMed ID: 35145399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
    Vliegenthart RJ; Ten Hove CH; Onland W; van Kaam AH
    Neonatology; 2017; 111(2):162-171. PubMed ID: 27760427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
    García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
    Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
    Kumral A; Tuzun F; Yesilirmak DC; Duman N; Ozkan H
    Acta Paediatr; 2012 Jul; 101(7):e299-303. PubMed ID: 22462821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
    Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
    Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we over-treating hypoxic spells in preterm infants?
    Conlon S; Di Fiore JM; Martin RJ
    Semin Fetal Neonatal Med; 2021 Jun; 26(3):101227. PubMed ID: 33736905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
    Dobson NR; Hunt CE
    Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
    Abu Jawdeh EG; O'Riordan M; Limrungsikul A; Bandyopadhyay A; Argus BM; Nakad PE; Supapannachart S; Yunis KA; Davis PG; Martin RJ
    J Neonatal Perinatal Med; 2013; 6(3):251-6. PubMed ID: 24246598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Caffeine in Noninvasive Respiratory Support.
    Dobson NR; Patel RM
    Clin Perinatol; 2016 Dec; 43(4):773-782. PubMed ID: 27837758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
    Saroha V; Patel RM
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101178. PubMed ID: 33168464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequelae of caffeine treatment in preterm infants with apnea.
    Gunn TR; Metrakos K; Riley P; Willis D; Aranda JV
    J Pediatr; 1979 Jan; 94(1):106-9. PubMed ID: 363996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine for Apnea of Prematurity: Too Much or Too Little of a Good Thing.
    Schmidt B
    J Pediatr; 2023 Aug; 259():113488. PubMed ID: 37201684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.